Incremental cost and length of stay associated with postprocedure delirium in transcatheter and surgical aortic valve replacement patients in the United States. Issue 6 (14th December 2018)

• Record Type: Journal Article
• Authors: Potter, Brian J.; Thompson, Christin; Green, Philip; Clancy, Seth
• Is Part Of: Catheterization and cardiovascular interventions. Volume 93:Issue 6(2019)
• Page Start: 1132
• Page End: 1136
• Publication Date: 2018-12-14
• Subjects: aortic -- aortic valve disease -- economics/cost‐effectiveness -- elderly patients -- surgery -- transcatheter valve implantation; Heart -- Diseases -- Diagnosis -- Periodicals; Cardiac catheterization -- Periodicals; 616.1207572
• DOI: 10.1002/ccd.28014
• Languages: English
• ISSNs: 1522-1946

Abstract

Abstract: Objectives: To explore the impact of post‐procedure delirium on resource utilization following transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively). Background: Postprocedure delirium is associated with worse long‐term survival after TAVR and SAVR. However, its effect on resource utilization has been understudied. Methods: Using the 2015 Medicare Provider Analysis and Review File (MedPAR), we retrospectively analyzed elderly (≥80 years) Medicare beneficiaries receiving either SAVR or endovascular TAVR in the United States. Multivariate regression models estimating hospitalization cost and length of stay (LoS) were adjusted for patient demographics, comorbidities, and nondelirium complications. Results: A total of 21, 088 discharges were available for analysis (12, 114 TAVR and 8, 974 SAVR). TAVR patients were older (87 ± 3.8 vs. 84 ± 2.7 years; P < 0.001) with a higher comorbidity burden (Charlson index 3.0 ± 1.8 vs. 2.1 ± 1.7; P < 0.0001). Despite this, fewer TAVR patients (1.6%) experienced postoperative delirium during the index hospitalization compared to surgical patients (3.6%; P < 0.0001). Delirium was associated with a 4.16 [3.51–4.81] day longer hospital LoS and $15, 592 ($12, 849–$18, 334) higher incremental hospitalization cost. When stratified by treatment approach, the adjusted incremental cost of delirium was +$13, 862 ($9, 431–$18, 292) with TAVR and +$16, 656 ($13, 177–$20, 136) with SAVR with an additional hospital LoS of +3.39 (2.34–4.43) days and +4.63 (3.81–5.45) days for TAVR and SAVR, respectively. Conclusions: Postprocedure delirium is associated with significantly increased hospitalization costs and LoS following AVR. TAVR was associated with a lower postoperative delirium rate compared to SAVR. Post‐TAVR delirium may be associated with less resource consumption than post‐SAVR delirium.